Veerhealth Signs Contract Manufacturing Deal with Top Marketplace
ECONOMY & POLICY

Veerhealth Signs Contract Manufacturing Deal with Top Marketplace

Veerhealth Care, Ayuveer, backed by Veerhealth Care's expertise in Ayurveda, specializes in crafting ayurvedic medicines and oral care products with natural ingredients. With a focus on quality and affordability, Ayuveer aims to offer an exceptional and safe daily care experience to its customers.

Veerhealth Care has entered into a strategic Contract Manufacturing Agreement with a company having top position in personal care segment on marketplace companies in the country for the production of its private-label personal care range of products.

Under the terms of the agreement, company will manufacture and supply personal care range of products exclusively tailored to the company's brand specifications and quality standards. Company is in the process of regulatory approval which is expected to be completed soon and commercial production is expected to begin soon.

This development is expected to have a positive impact on the company's revenue and capacity utilisation in the coming quarters.

Commenting on the achievement, Bhavin Shah - Managing Director of Veerhealth Care, said, “We are exhilarated to announce this partnership which marks a significant milestone in company's growth strategy, further strengthening our position in the personal care manufacturing sector.

To meet the increased demand from both Domestic and Exports, Company will be operating at Full capacity which will help in reducing the overall costs and boosting Total Income and PAT. In coming Quarters, we expect to more than fully recover the reduction in Total Income and PAT caused by USFDA Inspection as dispatches for Exports have started.

We are working aggressively towards business of manufacturing and exports of products under medical device category in the US. Company is expected to complete formalities pertaining to the medical device category with the USFDA.

Our ability to secure multiple high-value export orders, including those from top institutional suppliers, underscores the trust in our product, quality and commitment to excellence. The expansion of our manufacturing footprint further reflects our proactive approach to meeting growing demand and enhancing our production capabilities. These achievements are a testament to our strategy and pave the way for sustained growth and value creation in the coming quarters."

For successfully clearing the USFDA Inspection the Company had to expand, renovate and upgrade the Manufacturing facility due to which Production was impacted in the past 6-9 months, also Exports were halted for USFDA clearance which resulted in Inventory pile up. Company has now started dispatching for Exports.

Products / Services offered by Veerhealth Care:

Contract Manufacturing – Veerhealth Care manufacture products on behalf of Brands to meet their requirements. The Brands give the company specifications about the products to be manufactured.

White Labelling – Veerhealth Care manufactures generic products that retailers can sell under their own Brands.

Product Research & Development – Veerhealth Care has extensive in-house R&D facility for designing, testing and manufacturing. Company has the capability of creating various new products. Till now Company has launched more than 100 products through this.

Customised Product Formulations – Veerhealth Care has the capability of manufacturing specialised product formulations customised for the Brands. Due to customisation the products can meet the standard specifications of the Brands.

Veerhealth Care has established a new division focused on hospital care, which includes partnering with a leading manufacturer and exporter of medical equipment. This new division will offer a range of equipment, including ventilators, defibrillators, infusion pumps, syringe pumps, and other accessories. Company intends to supply these products to government organizations and hospitals.

VeerPlast is a division of Veerhealth Care. It is a plastic moulding company, providing high-quality plastic products to various industries. At VeerPlast, Company takes pride in being a manufacturer of high-quality toothbrushes, dedicated to promoting superior oral hygiene through precision and commitment to excellence.

The Company is expecting to get a substantial addition to its revenue in the current financial year. In F.Y. 2025-26, Company is expecting Total Revenues of Rs 305-400 million with PAT of 10 per cent.


Veerhealth Care, Ayuveer, backed by Veerhealth Care's expertise in Ayurveda, specializes in crafting ayurvedic medicines and oral care products with natural ingredients. With a focus on quality and affordability, Ayuveer aims to offer an exceptional and safe daily care experience to its customers.Veerhealth Care has entered into a strategic Contract Manufacturing Agreement with a company having top position in personal care segment on marketplace companies in the country for the production of its private-label personal care range of products.Under the terms of the agreement, company will manufacture and supply personal care range of products exclusively tailored to the company's brand specifications and quality standards. Company is in the process of regulatory approval which is expected to be completed soon and commercial production is expected to begin soon.This development is expected to have a positive impact on the company's revenue and capacity utilisation in the coming quarters.Commenting on the achievement, Bhavin Shah - Managing Director of Veerhealth Care, said, “We are exhilarated to announce this partnership which marks a significant milestone in company's growth strategy, further strengthening our position in the personal care manufacturing sector.To meet the increased demand from both Domestic and Exports, Company will be operating at Full capacity which will help in reducing the overall costs and boosting Total Income and PAT. In coming Quarters, we expect to more than fully recover the reduction in Total Income and PAT caused by USFDA Inspection as dispatches for Exports have started.We are working aggressively towards business of manufacturing and exports of products under medical device category in the US. Company is expected to complete formalities pertaining to the medical device category with the USFDA.Our ability to secure multiple high-value export orders, including those from top institutional suppliers, underscores the trust in our product, quality and commitment to excellence. The expansion of our manufacturing footprint further reflects our proactive approach to meeting growing demand and enhancing our production capabilities. These achievements are a testament to our strategy and pave the way for sustained growth and value creation in the coming quarters.For successfully clearing the USFDA Inspection the Company had to expand, renovate and upgrade the Manufacturing facility due to which Production was impacted in the past 6-9 months, also Exports were halted for USFDA clearance which resulted in Inventory pile up. Company has now started dispatching for Exports.Products / Services offered by Veerhealth Care:Contract Manufacturing – Veerhealth Care manufacture products on behalf of Brands to meet their requirements. The Brands give the company specifications about the products to be manufactured.White Labelling – Veerhealth Care manufactures generic products that retailers can sell under their own Brands.Product Research & Development – Veerhealth Care has extensive in-house R&D facility for designing, testing and manufacturing. Company has the capability of creating various new products. Till now Company has launched more than 100 products through this.Customised Product Formulations – Veerhealth Care has the capability of manufacturing specialised product formulations customised for the Brands. Due to customisation the products can meet the standard specifications of the Brands.Veerhealth Care has established a new division focused on hospital care, which includes partnering with a leading manufacturer and exporter of medical equipment. This new division will offer a range of equipment, including ventilators, defibrillators, infusion pumps, syringe pumps, and other accessories. Company intends to supply these products to government organizations and hospitals.VeerPlast is a division of Veerhealth Care. It is a plastic moulding company, providing high-quality plastic products to various industries. At VeerPlast, Company takes pride in being a manufacturer of high-quality toothbrushes, dedicated to promoting superior oral hygiene through precision and commitment to excellence.The Company is expecting to get a substantial addition to its revenue in the current financial year. In F.Y. 2025-26, Company is expecting Total Revenues of Rs 305-400 million with PAT of 10 per cent.

Next Story
Real Estate

Indian Real Estate Sector Sees Highest Capital Inflow in Seven Years

Equirus Capital, a leading full-service investment banking firm, has reported that India’s real estate sector has witnessed its highest capital inflow in seven years, with funds raised reaching ₹23,080 crore across 12 deals.According to Equirus Capital’s analysis, the cumulative capital raised by the sector since FY18 stands at ₹72,331 crore. Of this, Real Estate Investment Trusts (REITs) accounted for the largest share at ₹31,241 crore, followed by large-cap real estate companies at ₹20,437 crore, mid-cap players at ₹12,496 crore, and small-cap firms contributing ₹8,156 crore...

Next Story
Real Estate

India’s Flex Office Market Set for Record Growth

myHQ by ANAROCK, India’s largest workspace discovery and flexible office solutions platform, has released its Flex Office Market in India 2025 Report, revealing that India is set to become the Asia-Pacific region’s largest flexible office market. The report highlights how flexible workspaces have become a mainstream component of India’s commercial real estate, capturing a growing share of national leasing activity.“Flexible workspaces have evolved from a cost-optimisation tool to a strategic necessity,” said Utkarsh Kawatra, CEO and Co-Founder, myHQ by ANAROCK. “Average corporate d..

Next Story
Real Estate

India Defies Regional Slowdown; Office Leasing on Track for Record High in 2025

India’s office market continues to outperform the broader Asia-Pacific region, emerging as a key growth driver amid regional headwinds, according to Knight Frank’s Asia-Pacific Office Highlights Q3 2025 report. With 8.8 million sq. ft. transacted in the third quarter alone, leasing momentum remains robust. Full-year volumes across Bengaluru, NCR, and Mumbai are projected to reach 50 million sq. ft., surpassing the previous record of 41 million sq. ft. set in 2024.The surge has been fuelled by sustained leasing from Global Capability Centres (GCCs) and renewed activity from third-party IT s..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Talk to us?